168 related articles for article (PubMed ID: 33180162)
1. Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review.
Tsuruda KM; Hovda T; Bhargava S; Veierød MB; Hofvind S
Eur Radiol; 2021 May; 31(5):2677-2686. PubMed ID: 33180162
[TBL] [Abstract][Full Text] [Related]
2. Radiological review of prior screening mammograms of screen-detected breast cancer.
Hovda T; Tsuruda K; Hoff SR; Sahlberg KK; Hofvind S
Eur Radiol; 2021 Apr; 31(4):2568-2579. PubMed ID: 33001307
[TBL] [Abstract][Full Text] [Related]
3. True and Missed Interval Cancer in Organized Mammographic Screening: A Retrospective Review Study of Diagnostic and Prior Screening Mammograms.
Hovda T; Hoff SR; Larsen M; Romundstad L; Sahlberg KK; Hofvind S
Acad Radiol; 2022 Jan; 29 Suppl 1():S180-S191. PubMed ID: 33926794
[TBL] [Abstract][Full Text] [Related]
4. Missed and true interval and screen-detected breast cancers in a population based screening program.
Hoff SR; Samset JH; Abrahamsen AL; Vigeland E; Klepp O; Hofvind S
Acad Radiol; 2011 Apr; 18(4):454-60. PubMed ID: 21216632
[TBL] [Abstract][Full Text] [Related]
5. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
6. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.
Hofvind S; Skaane P; Vitak B; Wang H; Thoresen S; Eriksen L; Bjørndal H; Braaten A; Bjurstam N
Radiology; 2005 Nov; 237(2):437-43. PubMed ID: 16244251
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review.
Hoff SR; Abrahamsen AL; Samset JH; Vigeland E; Klepp O; Hofvind S
Radiology; 2012 Aug; 264(2):378-86. PubMed ID: 22700555
[TBL] [Abstract][Full Text] [Related]
8. Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study.
Tsuruda KM; Hoff SR; Akslen LA; Hofvind S
Br J Cancer; 2024 Jan; 130(1):99-107. PubMed ID: 38049556
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer missed at screening; hindsight or mistakes?
Hovda T; Larsen M; Romundstad L; Sahlberg KK; Hofvind S
Eur J Radiol; 2023 Aug; 165():110913. PubMed ID: 37311339
[TBL] [Abstract][Full Text] [Related]
10. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
[TBL] [Abstract][Full Text] [Related]
11. AI-based prevention of interval cancers in a national mammography screening program.
Byng D; Strauch B; Gnas L; Leibig C; Stephan O; Bunk S; Hecht G
Eur J Radiol; 2022 Jul; 152():110321. PubMed ID: 35512511
[TBL] [Abstract][Full Text] [Related]
12. How do AI markings on screening mammograms correspond to cancer location? An informed review of 270 breast cancer cases in BreastScreen Norway.
Koch HW; Larsen M; Bartsch H; Martiniussen MA; Styr BM; Fagerheim S; Haldorsen IHS; Hofvind S
Eur Radiol; 2024 Feb; ():. PubMed ID: 38396248
[TBL] [Abstract][Full Text] [Related]
13. [Breast carcinoma diagnosed in mammographic screening incidentally. Research on the radiologic signs in prior mammograms].
Marra V; Frigerio A; Di Virgilio MR; Menna S; Burke P
Radiol Med; 1999 Nov; 98(5):342-6. PubMed ID: 10780212
[TBL] [Abstract][Full Text] [Related]
14. Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.
van Bommel RMG; Weber R; Voogd AC; Nederend J; Louwman MWJ; Venderink D; Strobbe LJA; Rutten MJC; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
BMC Cancer; 2017 May; 17(1):315. PubMed ID: 28476109
[TBL] [Abstract][Full Text] [Related]
15. The incidence and 10-year survival of interval breast cancers in Wales.
Fong Y; Evans J; Brook D; Kenkre J; Jarvis P; Gower Thomas K
Clin Radiol; 2014 Apr; 69(4):e168-72. PubMed ID: 24457014
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
17. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
18. Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.
Nykänen A; Sudah M; Masarwah A; Vanninen R; Okuma H
Sci Rep; 2024 May; 14(1):10001. PubMed ID: 38693256
[TBL] [Abstract][Full Text] [Related]
19. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
[TBL] [Abstract][Full Text] [Related]
20. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
Domingo L; Salas D; Zubizarreta R; Baré M; Sarriugarte G; Barata T; Ibáñez J; Blanch J; Puig-Vives M; Fernández A; Castells X; Sala M;
Breast Cancer Res; 2014 Jan; 16(1):R3. PubMed ID: 24410848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
